Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Regression of Epithelial Cancers Following T Cell Receptor Gene Therapy Targeting Human Papillomavirus-16 E7

Scott Michael Norberg, DO, Nisha Nagarsheth, PhD, Stacey Doran, MD, Jennifer A Kanakry, MD, Sabina Adhikary, PhD, Colleen Schweitzer, PhD, Stephanie H Astrow, PhD, William Faquin, MD, Nikolaos Gkitsas, Steven Highfill, PhD, Christian S Hinrichs

Blood (2018) 132 (Supplement 1): 492.

https://doi.org/10.1182/blood-2018-99-117017

Published: 2018

Journal Articles

Risk for New Malignancies of Potential Infectious Etiology Among Adult Survivors of Specific Non-Hodgkin Lymphoma Subtypes

Megan M Herr, PhD, Sara J. Schonfeld, PhD, Graca M. Dores, MD MPH, Margaret A. Tucker, MD, Rochelle E Curtis, MA, Lindsay M Morton, PhD

Blood (2016) 128 (22): 2414.

https://doi.org/10.1182/blood.V128.22.2414.2414

Published: 2016

Journal Articles

Diffuse Large B-Cell Lymphoma Survivorship: Risk of Second Malignancies in Long Term Survivors

Lakshmi Suryateja Gangavarapu, Rakesh Surapaneni, MD

Blood (2015) 126 (23): 3921.

https://doi.org/10.1182/blood.V126.23.3921.3921

Published: 2015

Journal Articles

R-HCVAD Alternating with R-Methotrexate Cytarabine in Younger Patients (pts) with IH and High-Risk Age Adjusted-IPI DLBCL

Yasuhiro Oki, MD, Jason R. Westin, MD, Nathan Fowler, MD, Sattva Neelapu, MD, F.B. Hagemeister, MD, Peter McLaughlin, MD, Larry W. Kwak, MD, PhD, Jorge Enrique Romaguera, Michelle Fanale, MD, Anas Younes, MD, Maria A. Rodriguez, MD, Robert Z. Orlowski, MD, PhD, Michael Wang, M.D., Souzanne T Ouzounian, Felipe Samaniego, M.D., Luis Fayad, MD

Blood (2012) 120 (21): 3707.

https://doi.org/10.1182/blood.V120.21.3707.3707

Published: 2012

Journal Articles

Second Malignancies After Treatment of AIDS-Related Non-Hodgking's Lymphoma

Jose Tomas Navarro, MD, PhD, Maria Joao Baptista, Mireia Morgades, Cristina Tural, MD, PhD, Evarist Feliu, MD, PhD, Fuensanta Millá, MD, PhD, Josep-Maria Ribera, MD, PhD

Blood (2011) 118 (21): 4943.

https://doi.org/10.1182/blood.V118.21.4943.4943

Published: 2011

Journal Articles

Single Agent Metronomic Cyclophosphamide in Refractory,Non-Hodgkin's Lymphoma.

Caroline Hamm, MD, Sindu M. Kanjeekal, MD, FRCP(C), John Mathews, MD, FRCP(C), Yasmin Alam, Sam Yoshida, Tarek Elfiki

Blood (2009) 114 (22): 4776.

https://doi.org/10.1182/blood.V114.22.4776.4776

Published: 2009

NARROW

Regression of Epithelial Cancers Following T Cell Receptor Gene Therapy Targeting Human Papillomavirus-16 E7

Risk for New Malignancies of Potential Infectious Etiology Among Adult Survivors of Specific Non-Hodgkin Lymphoma Subtypes

Diffuse Large B-Cell Lymphoma Survivorship: Risk of Second Malignancies in Long Term Survivors

R-HCVAD Alternating with R-Methotrexate Cytarabine in Younger Patients (pts) with IH and High-Risk Age Adjusted-IPI DLBCL

Second Malignancies After Treatment of AIDS-Related Non-Hodgking's Lymphoma

Single Agent Metronomic Cyclophosphamide in Refractory,Non-Hodgkin's Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Regression of Epithelial Cancers Following T Cell Receptor Gene Therapy Targeting Human Papillomavirus-16 E7

Risk for New Malignancies of Potential Infectious Etiology Among Adult Survivors of Specific Non-Hodgkin Lymphoma Subtypes

Diffuse Large B-Cell Lymphoma Survivorship: Risk of Second Malignancies in Long Term Survivors

R-HCVAD Alternating with R-Methotrexate Cytarabine in Younger Patients (pts) with IH and High-Risk Age Adjusted-IPI DLBCL

Second Malignancies After Treatment of AIDS-Related Non-Hodgking's Lymphoma

Single Agent Metronomic Cyclophosphamide in Refractory,Non-Hodgkin's Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only